Introduction
Angiogenesis is a physiological response to ischemia (1) . Neovascularization of ischemic muscle may be sufficient to preserve tissue integrity and/or function. Therapeutic angiogenesis, a strategy to cure tissue ischemia by promoting collateral growth, has emerged as one of the most promising therapies for ischemic diseases to date (2) . Clinical trials of therapeutic angiogenesis in patients with end-stage coronary artery disease have shown large increases in exercise time and marked reductions in symptoms of angina, as well as objective evidence of improved perfusion and left ventricular function (2) (3) (4) (5) . On the other hand, angiogenesis is necessary system is involved not only in apoptosis but also in cell-activation signals. Recently, it was reported that local stimulation of Fas in vivo using an agonistic antibody triggers inflammatory cell infiltration and neoangiogenesis independently of apoptosis (17) . This report has raised clinical interest in the potential use of Fas agonists for therapeutic angiogenesis. On the other hand, Fas/FasL interaction has been shown to inhibit pathological angiogenesis by controlling the growth and development of new subretinal vessels that can damage vision (18) .
Here, we took advantage of mouse genetics to elucidate the controversial role of the Fas/FasL system in angiogenesis. We induced hindlimb ischemia in wild-type, gld (Fas ligand / ) and lpr (Fas / ) mice. There was no significant difference in the recovery of blood flow or in the number of capillaries. We also found a similar degree of inflammatory cell infiltration and vascular endothelial growth factor (VEGF) expression among the three strains. Our findings indicate that ischemia-induced angiogenesis can occur independently of the Fas/FasL interaction.
Materials and Methods

Animals
C57BL/6J, B6-gld (FasL / ), and B6-lpr (Fas / ) mice were purchased from Japan SLC, Inc. (Shizuoka, Japan), kept in microisolator cages under a 12-h day/night cycle and fed with regular feed. For all surgical procedures, the mice were anesthetized by intraperitoneal injection of 50 mg/kg Nembutal (Abbott Laboratories, North Chicago, USA) diluted in 0.9% sodium chloride solution. All procedures involving experimental animals were performed in accordance with protocols approved by local institutional guidelines for animal care of the University of Tokyo and complied with the "Guide for the Care 
A B Mouse Ischemic Hindlimb Model
Unilateral hindlimb ischemia was induced in 8-week-old male C57BL/6J, B6-gld (FasL / ), and B6-lpr (Fas / ) mice (19) . The proximal and distal portions of the femoral artery and the distal portion of the saphenous artery were ligated. The arteries and all side branches were then dissected free and excised. The skin was closed with 5-0 surgical sutures. Hindlimb blood perfusion was measured with a Laser Doppler perfusion imager (LDPI) system (Moor Instruments Ltd., Devon, UK) (19) . Excess hairs were removed from the limbs using depilatory cream before imaging, and mice were placed on a heating plate at 40ºC. To avoid the influence of ambient light and temperature, the results are expressed as the ratio of perfusion in the right (ischemic) to that in the left (untreated) limb. At 5 weeks after surgery, mice were sacrificed by intraperitoneal injection of an overdose of Nembutal. The ischemic calf muscles were fixed in methanol and embedded in paraffin. Sections (5 µm) were de-paraffinized and incubated with a rat-monoclonal antibody against murine CD31 (clone MEC13.1; BD PharMingen, San Diego, USA). Antibody distribution was visualized using the avidin-biotin-complex technique and Vector Red substrate (Vector Laboratories, Burlingame, USA), followed by counterstaining with hematoxylin. Capillaries were identified by positive staining for CD31 and morphology. Ten different fields from each tissue preparation were randomly selected, and capillaries were counted. Capillary density was expressed as the number of capillaries per mm 2 .
Immunohistochemistry for Inflammatory Cells and VEGF
Paraffin-embedded sections (5-µm thick) were deparaffinized and blocked with 1% rabbit serum. T lymphocytes, macrophages, and VEGF were detected by immunostaining with anti-CD3ε hamster monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, USA), anti-F4/80 monoclonal antibody (clone A3-1; Serotec, Washington DC, USA) and anti-VEGF goat polyclonal antibody (R&D Systems, Minneapolis, USA) respectively, followed by the avidin-biotin complex technique and Vector Red substrate (Vector Laboratories). Sections were counterstained with hematoxylin.
Injection of Anti-Fas Antibody
Agonistic anti-Fas antibody (clone Jo2) was purchased from PharMingen (San Diego, USA) (20) . The antibody was diluted in PBS and administered to 8-week-old male C57 and B6-lpr (Fas / ) mice (Japan SLC, Inc.) intravenously through the tail vein (0.5 µg/g). The liver tissues were removed at death, fixed with 4% paraformaldehyde in PBS (pH 7.4) and embedded in paraffin. At 3 h after the injection, surviving mice were euthanized by intraperitoneal administration of an overdose of Nembutal, after which the liver tissues were excised. Paraffin-embedded sections were stained with hematoxylin and eosin. 
Results
Blood Flow Recovery after Acute Hindlimb Ischemia in Wild-type, gld, and lpr Mice
To study the potential involvement of Fas/FasL interaction in ischemia-induced angiogenesis, we compared the blood flow recovery after acute ischemia in wild-type mice with that in gld or lpr mice, which lack FasL or Fas, respectively. After inducing hindlimb ischemia in C57BL/6J, B6-gld, and B6-lpr mice (n 5 for each group), we monitored the blood flow of the ischemic and non-ischemic legs using a Laser Doppler imaging system (Fig. 1) . Resection of the right femoral artery induced marked reduction of blood flow, which was recovered gradually. There was no significant difference in blood flow of the ischemic leg among the mice at any time points. At 5 weeks, we sacrificed the mice and harvested the ischemic calf muscles for histological examination. Consistent with the measurement by Laser Doppler imaging, anti-CD31 immunostaining revealed no significant difference in the capillary density of the ischemic legs among the three strains (Fig. 2) .
Fig. 3. Inflammatory cell infiltration and VEGF expression in wild-type, gld (FasL / ) and lpr (Fas / ) mice. Paraffinembedded sections of ischemic muscles were deparaffinized and stained with specific antibodies to detect macrophages (F4/80), T cells (CD3ε) and VEGF using the avidin-biotin complex technique and Vector
Inflammatory Cell Infiltration and VEGF Expression in
Wild-Type, gld, and lpr Mice Next, we investigated the infiltration of inflammatory cells in ischemic muscles, because previous studies have suggested that such cells play a critical role in ischemia-induced angiogenesis (17, 21) . We found infiltration of T cells and macrophages in the ischemic muscles (Fig. 3) . The number of inflammatory cells in wild-type mice was not significantly different from that in FasL / or Fas / mice (Table 1) .
Immunostaining for VEGF demonstrated no difference in VEGF expression of the ischemic muscles among the three strains.
Lack of Fas-Mediated Apoptosis in Fas-Deficient Mice
To demonstrate the lack of Fas-mediated apoptosis in lpr mice, wild-type mice and lpr mice were challenged with an agonistic anti-Fas antibody (20) . Consistent with the results of a previous report (20) , intravenous injection of the antiFas antibody killed all wild-type mice (n 3) within 3 h, whereas no lpr mouse died. Histological examination revealed fulminant liver injury with diffuse hemorrhage and massive apoptosis of hepatocytes in the liver of wild-type mice, whereas the liver of the lpr mice appeared intact (Fig.  4 ). These findings demonstrate that the lpr mice used in this study were in fact deficient in Fas-mediated apoptosis.
Discussion
In this study, we evaluated the potential involvement of Fasmediated signaling in ischemia-induced angiogenesis. There was no significant difference in physiological blood flow recovery or histological capillary density among the mice. We found a similar degree of inflammatory response and VEGF expression in the ischemic muscles of wild-type, FasL / , and Fas / mice. Our findings provide a crucial insight into the controversial role of Fas-mediated signaling in angiogenesis, apoptosis, inflammation and proliferation in the vessel wall (17, 18, (22) (23) (24) (25) . Vascular smooth muscle cells abundantly express Fas (26, 27) , and the expression of this receptor is regulated by cytokines (23, 27) and a tumor suppressor gene p53 (25) . Numerous studies have shown that Fas is implicated in smooth muscle apoptosis in vascular lesions (22) (23) (24) (25) . An appreciable amount of Fas has also been detected on vascular endothelial cells (23, (27) (28) (29) (30) . However, vascular endothelial cells are resistant to anti-Fas agonists (27) (28) (29) , suggesting that Fas-mediated signals may play a role in various cellular events other than apoptosis. Recent studies have clarified the role of Fas in the transduction of growth-promoting signals in T cells (31) , cardiomyocytes (32) , fibroblasts (33) , and hepatocytes (34) . Moreover, it was demonstrated that the activation of Fas in peritoneal exudates cells provoked inflammatory responses by stimulating the release of IL-1 (35) . It was also suggested that Fas-mediated signaling contributes to inflammatory response in vessel walls and, therefore, promotes angiogenesis (35, 36) . In the present study, mice deficient for Fas or FasL displayed collateral vessel growth similar to that observed in wild-type mice. We found no significant difference in inflammatory cell infiltration or in VEGF expression among the three strains. These data do not support the hypothesis that the Fas/FasL system plays a major role in promoting inflammation and angiogenesis, at least in ischemic tissues.
In this study, excision of the right femoral artery of young mice (8-week-old, C57BL/6J background) produced severe ischemia in the leg (blood flow ratio: 0.2-0.4). However, the blood flow was almost normalized at 1 week after excision. Therefore, our results would not exclude the potential involvement of the Fas/FasL system in the process of angiogenesis that occurs in chronically ischemic tissues.
In conclusion, our results indicate that Fas/FasL interaction may not be essential to physiological angiogenesis in response to acute ischemia. Further studies will be needed to identify the molecular signaling pathways that mediate inflammatory cell infiltration and collateral vessel growth.
